Innovator Ibd 50 Etf Market Value
| FFTY Etf | USD 37.74 0.49 1.28% |
| Symbol | Innovator |
The market value of Innovator IBD 50 is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator IBD's value that differs from its market value or its book value, called intrinsic value, which is Innovator IBD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator IBD's market value can be influenced by many factors that don't directly affect Innovator IBD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator IBD's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator IBD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Innovator IBD's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Innovator IBD 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Innovator IBD's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Innovator IBD.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Innovator IBD on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Innovator IBD 50 or generate 0.0% return on investment in Innovator IBD over 90 days. Innovator IBD is related to or competes with Fidelity Disruptors, Rbb Fund, ALPS Clean, ETF Series, Motley Fool, AIM ETF, and Invesco Bloomberg. The fund will normally invest at least 80 percent of its net assets in securities that comprise the index More
Innovator IBD Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Innovator IBD's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Innovator IBD 50 upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.78 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 11.82 | |||
| Value At Risk | (4.20) | |||
| Potential Upside | 3.78 |
Innovator IBD Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innovator IBD's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Innovator IBD's standard deviation. In reality, there are many statistical measures that can use Innovator IBD historical prices to predict the future Innovator IBD's volatility.| Risk Adjusted Performance | 0.0279 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0393 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innovator IBD's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Innovator IBD February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0279 | |||
| Market Risk Adjusted Performance | 0.0493 | |||
| Mean Deviation | 1.74 | |||
| Semi Deviation | 2.63 | |||
| Downside Deviation | 2.78 | |||
| Coefficient Of Variation | 3808.97 | |||
| Standard Deviation | 2.43 | |||
| Variance | 5.91 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0393 | |||
| Maximum Drawdown | 11.82 | |||
| Value At Risk | (4.20) | |||
| Potential Upside | 3.78 | |||
| Downside Variance | 7.75 | |||
| Semi Variance | 6.91 | |||
| Expected Short fall | (1.61) | |||
| Skewness | (0.50) | |||
| Kurtosis | 1.44 |
Innovator IBD 50 Backtested Returns
Innovator IBD appears to be very steady, given 3 months investment horizon. Innovator IBD 50 holds Efficiency (Sharpe) Ratio of 0.0913, which attests that the entity had a 0.0913 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Innovator IBD 50, which you can use to evaluate the volatility of the entity. Please utilize Innovator IBD's Downside Deviation of 2.78, risk adjusted performance of 0.0279, and Market Risk Adjusted Performance of 0.0493 to validate if our risk estimates are consistent with your expectations. The etf retains a Market Volatility (i.e., Beta) of 1.37, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Innovator IBD will likely underperform.
Auto-correlation | 0.21 |
Weak predictability
Innovator IBD 50 has weak predictability. Overlapping area represents the amount of predictability between Innovator IBD time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Innovator IBD 50 price movement. The serial correlation of 0.21 indicates that over 21.0% of current Innovator IBD price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | 0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 1.34 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Innovator IBD 50 offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innovator IBD's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innovator Ibd 50 Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Innovator Ibd 50 Etf:Check out Innovator IBD Correlation, Innovator IBD Volatility and Innovator IBD Performance module to complement your research on Innovator IBD. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Innovator IBD technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.